Loading clinical trials...
Loading clinical trials...
A Phase I/IIa Dose-Ranging Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BA-210 and the Neurological Status of Patients Following Administration of a Single Extradural Application of Cethrin During Surgery for Acute Thoracic and Cervical Spinal Cord Injury
Conditions
Interventions
Cethrin
Locations
8
United States
St. Joseph's Hospital & Medical Center
Phoenix, Arizona, United States
University of Cincinnati Mayfield Clinic and Spine Institute
Cincinnati, Ohio, United States
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Univ.of Virginia Health System
Charlottesville, Virginia, United States
University of Washington Harborview Medical Center
Seattle, Washington, United States
Sunnybrooke Health Sciences Centre
Toronto, Ontario, Canada
Start Date
February 1, 2005
Primary Completion Date
December 1, 2008
Completion Date
February 1, 2009
Last Updated
April 14, 2016
NCT04894734
NCT06587607
NCT07293780
NCT06611748
NCT06841770
NCT07357428
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions